Swiss Approval of Coartem Baby Marks Major Advance in Infant Malaria Treatment
-
最新报道：Swiss authorities have approved Coartem Dispersible, a child-friendly malaria treatment developed by Novartis and Medicines for Malaria Venture, marking a significant advancement in infant care. The strawberry-flavored tablet dissolves in water, addressing challenges of administering bitter anti-malarials to children. This approval follows WHO prequalification, enabling distribution in malaria-endemic regions where the disease claims a child's life every two minutes. Novartis CEO Vas Narasimhan emphasized this milestone in their 20-year partnership to combat malaria, while MMV's David Reddy highlighted its potential to save young lives in high-burden areas. The treatment combines artemether and lumefantrine, proven effective against Plasmodium falciparum malaria.
下一篇
New Indicator Suggests a Recession Is Likely To Come in 2 Months
- A new economic indicator suggests a potential recession could hit within two months, accor...
24小时热点
热点专题
407297